Olema Pharmaceuticals, Inc. (OLMA) Institutional Ownership

Ownership Summary

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) showed up in the 13F filings of 197 institutional investors as of December 2025.

• Collectively, these holders controlled 104.7% of Olema Pharmaceuticals's outstanding shares in December 2025, up from 80.6% in September 2025.
• They increased total shares held in OLMA by 37.72% quarter over quarter, and investors in Olema Pharmaceuticals increased 25.48% from a year ago.
• Of these 197 funds, 139 grew their exposure to Olema Pharmaceuticals, 39 cut back, and 19 maintained positions.
• Altogether, these fund groups held 89.77Mn shares in OLMA by December 2025, up by 24.59Mn shares quarter on quarter, and up 15.37Mn shares year over year.
• Janus Henderson Group Plc holds the largest position in OLMA at 14.22Mn shares as of December 31, 2025, or 16.58% of shares outstanding.
• The biggest buyers of Olema Pharmaceuticals for the quarter ending December 2025 included Janus Henderson Group Plc (7.51Mn), FMR LLC (5.36Mn), VANGUARD CAPITAL MANAGEMENT LLC (3.08Mn), State Street Corp (2.05Mn), Siren, L.L.C. (1.46Mn).
• The largest sales of OLMA for the quarter ending December 2025 came from Franklin Resources Inc (1.26Mn), Vestal Point Capital, LP (1.22Mn), Bain Capital Life Sciences Investors, LLC (1.04Mn), Goldman Sachs Group Inc (590.19K), Lightspeed Management Company, L.L.C. (575.6K).
• Olema Pharmaceuticals's 10 largest shareholders as of December 2025 include Janus Henderson Group Plc (14.22Mn), FMR LLC (10.39Mn), Paradigm Biocapital Advisors LP (8.02Mn), Bain Capital Life Sciences Investors, LLC (7.47Mn), BlackRock, Inc. (5.65Mn), BVF INC/IL (5.3Mn), Siren, L.L.C. (4.76Mn), State Street Corp (3.94Mn), Cormorant Asset Management, LP (3.9Mn), Logos Global Management LP (3.21Mn) per Business Quant data.